Journal
DIABETES TECHNOLOGY & THERAPEUTICS
Volume 15, Issue 1, Pages 101-115Publisher
MARY ANN LIEBERT, INC
DOI: 10.1089/dia.2012.0188
Keywords
-
Categories
Funding
- Imperial NIHR Biomedical Research Centre
- MRC [MC_PC_12015] Funding Source: UKRI
- Medical Research Council [MC_PC_12015] Funding Source: researchfish
Ask authors/readers for more resources
Microneedle array devices provide the opportunity to overcome the barrier characteristics of the outermost skin layer, the stratum corneum. This novel technology can be used as a therapeutic tool for transdermal drug delivery, including insulin, or as a diagnostic tool providing access to dermal biofluids, with subsequent analysis of its contents. Over the last decade, the use of microneedle array technology has been the focus of extensive research in the field of transdermal drug delivery. More recently, the diagnostic applications of microneedle technology have been developed. This review summarizes the existing evidence for the use of microneedle array technology as biosensors for continuous monitoring of the glucose content of interstitial fluid, focusing also on mechanics of insertion, microchannel characteristics, and safety profile.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available